These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 16125814)
1. The potential for gene-targeted radiation therapy of cancers. Panyutin IG; Neumann RD Trends Biotechnol; 2005 Oct; 23(10):492-6. PubMed ID: 16125814 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy strategies to enhance the effectiveness of cancer radiotherapy. Freyta SO; Kim JH; Brown SL; Barton K; Lu M; Chung M Curr Opin Mol Ther; 2004 Oct; 6(5):513-24. PubMed ID: 15537053 [TBL] [Abstract][Full Text] [Related]
3. Approaches to enhance cancer radiotherapy employing gene transfer methods. Buchsbaum DJ; Raben D; Stackhouse MA; Khazaeli MB; Rogers BE; Rosenfeld ME; Liu T; Curiel DT Gene Ther; 1996 Dec; 3(12):1042-68. PubMed ID: 8986431 [TBL] [Abstract][Full Text] [Related]
4. Tumor hypoxia and targeted gene therapy. Greco O; Scott S Int Rev Cytol; 2007; 257():181-212. PubMed ID: 17280898 [TBL] [Abstract][Full Text] [Related]
5. [Current status of gene therapy for cancers]. Kudo-Saito C Gan To Kagaku Ryoho; 2007 Sep; 34(9):1341-6. PubMed ID: 17876128 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Strategies for selective targeting of Auger electron emitters to tumor cells. O'Donoghue JA J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620 [TBL] [Abstract][Full Text] [Related]
9. Defining a future role for radiogenic therapy. Kaminski JM; Kaminski RJ; Dicker AP; Urbain JL Cancer Treat Rev; 2001 Oct; 27(5):289-94. PubMed ID: 11871865 [TBL] [Abstract][Full Text] [Related]
10. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery. Thorne SH; Contag CH Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814 [TBL] [Abstract][Full Text] [Related]
11. A new era of cancer therapy: cancer cell targeted therapies are coming of age. Voltz E; Gronemeyer H Int J Biochem Cell Biol; 2008; 40(1):1-8. PubMed ID: 17951100 [TBL] [Abstract][Full Text] [Related]
12. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Dorer DE; Nettelbeck DM Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376 [TBL] [Abstract][Full Text] [Related]